In Parkinson’s, Dementia May Occur Less Often, or Later, than Thought

There’s some good news for people with Parkinson’s disease: The risk of developing dementia may be lower than previously thought, or dementia may occur later in the course of the disease than previously reported, according to a study published in the August 7, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

CUVET Answers All Your Questions Related to “Rabies” while Campaigning for Vaccination in High-Risk Groups to Prevent Fatal Communicable Disease

Chula Veterinary Science joined the World Rabies Day campaign on September 28, to educate and raise awareness about rabies, and organize vaccinations for veterinarian science students who volunteered in the community, while emphasizing that people at risk should be vaccinated regularly against rabies.

Most COVID-19 long-haulers continue to experience neurologic symptoms, fatigue, and compromised quality of life 15 months after initial infection

A new study published in Annals of Clinical and Translational Neurology looked at the evolution of neurologic symptoms in non-hospitalized COVID-19 long-haulers at the Northwestern Medicine Neuro COVID-19 Clinic and discovered most long-haulers continue to experience symptoms such as brain fog, numbness/tingling, headache, dizziness, blurred vision, tinnitus and fatigue on average of 15 months after disease onset.

Finding Right Drug Balance for Parkinson’s Patients

Parkinson’s disease is most commonly treated with levodopa, but the benefits wear off as the disease progresses and high doses can result in dyskinesia, which are involuntary and uncontrollable movements. To better understand the underlying reasons behind these effects, researchers created a model of the interactions between levodopa, dopamine, and the basal ganglia, an area of the brain that plays a crucial role in Parkinson’s disease. They discuss their findings in the journal Chaos.

Rutgers Expert Available to Comment on COVID-19 Neurological Effects in Seniors

Dr. XinQi Dong, MD, MPH, director of the Institute for Health, Health Care Policy and Aging Research at Rutgers University-New Brunswick, is available to comment on the importance of further research into neurological effects of COVID-19 that may be related…

The CNS Announces a New Addition to its NEUROSURGERY® Publications Suite of Journals

The Congress of Neurological Surgeons (CNS) is pleased to announce the debut of its latest journal, Neurosurgery Open. The goal of Neurosurgery Open is to provide an outlet for the publication of scientific papers dealing with clinical neurosurgery and experimental neurosurgery

Congress of Neurological Surgeons Hosts 2019 Annual Meeting in San Francisco, October 19–23

Schaumburg, Illinois, August 21, 2019 — The Congress of Neurological Surgeons (CNS) is proud to host its 67th Annual Meeting in San Francisco, California, October 19–23. Each year, thousands of neurosurgeons, advanced practice providers, health care advocates, and other professionals from around the world gather to celebrate and learn about the advances are being made in the field of neurosurgery.

CNS Publishes Guidelines for Pediatric Myelomeningocele

The Congress of Neurological Surgeons (CNS) has developed an evidence-based guideline for the treatment of patients with myelomeningocele. Executive summaries of the Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for Pediatric Myelomeningocele were published today in Neurosurgery. Full text of the guidelines can also be found on cns.org.